CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The European Liquid Biopsy Academy (ELBA) aims to advance liquid biopsy technologies for cancer diagnostics. It trains early-stage researchers in various disciplines to overcome barriers in the development and commercialization of blood-based diagnostic methods.
Liquid biopsies have been heralded as a game changer in cancer management, with blood tests offering a minimally invasive, safe, and sensitive alternative or complimentary approach for tissue biopsies.
Blood represents a rich source of information through which solid cancers (and their subtypes) can be detected, identified and classified, and matched to a specific therapy.
However, despite the potential of individual approaches, the promise of liquid biopsies has not yet materialised in the clin…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Hamburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Badalona Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
Portugal, Lisboa
Type: Research institute
Activity type: Research Organisations
SME: No
CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER
France, Montpellier
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
